Suppr超能文献

BAMBI 的过表达及其在人骨肉瘤细胞生长和侵袭中的作用。

The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.

机构信息

Department of Orthopaedic Surgery, Chonbuk National University Medical School, Jeonju 561-756, Republic of Korea.

出版信息

Oncol Rep. 2013 Sep;30(3):1315-22. doi: 10.3892/or.2013.2569. Epub 2013 Jun 26.

Abstract

The pseudoreceptor BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor), formerly known as NMA, is an inhibitor of the TGF-β signaling pathway. BAMBI exhibits structural homology to TGF-βRI but lacks an intracellular kinase domain. In most of the high-grade carcinomas, the degree of BAMBI expression is abnormally increased, which leads to the proliferation and metastasis of tumor cells. Recent studies have reported that BAMBI is involved in the Wnt-β-catenin pathway that regulates the proliferation and metastasis of tumor cells. However, little is known about the role of BAMBI and β-catenin in human osteosarcoma. Given the above background, we examined the role of BAMBI in the pathophysiology of osteosarcoma. Using immunohistochemical staining and western blot analysis, the degree of the expression of BAMBI and β-catenin was significantly higher in osteosarcoma specimens compared with normal tissues. With the overexpression of BAMBI, mediated by adenovirus, the degree of invasion and migration was significantly increased and the proliferation of U2-OS osteosarcoma cells was stimulated. Transwell analysis showed that BAMBI increased the invasion of osteosarcoma cells and upregulated the secretion of matrix metalloproteinases (MMPs), which was demonstrated by gelatin zymography. Fluorescence-activated cell sorting (FACS) analysis showed a significant arrest in cell cycle progression at G0/G1 in osteosarcoma cells transfected with siRNA targeting BAMBI. With the overexpression of BAMBI, mediated by the adenovirus, however, there was a decrease in the number of cells at G0/G1. Consistent with the findings that cell growth was increased, BAMBI promoted the transition from G0/G1 to G2/M in the osteosarcoma cells. Our results suggest that BAMBI plays a key role in the pathogenesis and progression of osteosarcoma by regulating the expression of β-catenin and other signaling molecules via the pathways involved in the regulation of the cell cycle. This relationship between BAMBI and its involvement in the regulation of the cell cycle would provide a possibility that the BAMBI may be a new target for gene therapy.

摘要

BAMBI(骨形态发生蛋白和激活素的膜结合抑制剂)是 TGF-β信号通路的抑制剂,又称为 NMA,它是一种跨膜蛋白,与 TGF-βRI 具有结构同源性,但缺乏细胞内激酶结构域。在大多数高级别癌中,BAMBI 的表达程度异常增加,导致肿瘤细胞的增殖和转移。最近的研究表明,BAMBI 参与调节肿瘤细胞增殖和转移的 Wnt-β-catenin 通路。然而,关于 BAMBI 和β-catenin 在人骨肉瘤中的作用知之甚少。鉴于上述背景,我们研究了 BAMBI 在骨肉瘤病理生理学中的作用。通过免疫组织化学染色和 Western blot 分析,与正常组织相比,骨肉瘤标本中 BAMBI 和β-catenin 的表达程度显著升高。通过腺病毒介导的 BAMBI 过表达,U2-OS 骨肉瘤细胞的侵袭和迁移程度显著增加,增殖受到刺激。Transwell 分析表明,BAMBI 增加了骨肉瘤细胞的侵袭,并上调了基质金属蛋白酶(MMPs)的分泌,明胶酶谱法证实了这一点。荧光激活细胞分选(FACS)分析显示,靶向 BAMBI 的 siRNA 转染的骨肉瘤细胞在细胞周期 G0/G1 期有明显的阻滞。然而,通过腺病毒介导的 BAMBI 过表达,G0/G1 期的细胞数量减少。与细胞生长增加的结果一致,BAMBI 促进了骨肉瘤细胞从 G0/G1 期向 G2/M 期的转变。我们的结果表明,BAMBI 通过调节β-catenin 和其他信号分子的表达,通过参与细胞周期调控的途径,在骨肉瘤的发病机制和进展中发挥关键作用。BAMBI 与细胞周期调控的关系为 BAMBI 作为基因治疗的新靶点提供了可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验